Is low ApoB cholesterol good?

Low ApoB cholesterol is generally beneficial for heart health, with optimal levels below 80 mg/dL reducing cardiovascular disease risk. However, extremely low levels (below 40 mg/dL) may indicate underlying health issues requiring medical evaluation.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

What Is ApoB and Why Does It Matter?

Apolipoprotein B (ApoB) is a protein found on the surface of atherogenic lipoproteins—the particles that carry cholesterol through your bloodstream and can contribute to plaque buildup in your arteries. Unlike traditional cholesterol tests that measure the cholesterol content within these particles, ApoB testing counts the actual number of potentially harmful particles circulating in your blood.

Each atherogenic particle—including LDL (low-density lipoprotein), VLDL (very low-density lipoprotein), IDL (intermediate-density lipoprotein), and Lp(a)—contains exactly one ApoB protein. This one-to-one relationship makes ApoB measurement a direct count of all the particles that can penetrate your arterial walls and cause atherosclerosis, the underlying process behind heart attacks and strokes.

Research increasingly shows that ApoB is a superior predictor of cardiovascular disease compared to LDL cholesterol alone. While LDL-C measures the cholesterol cargo, ApoB counts the vehicles carrying that cargo—and it's the number of vehicles that determines your risk. Understanding your ApoB levels can help you make informed decisions about your cardiovascular health.

ApoB Level Categories and Cardiovascular Risk

ApoB Level (mg/dL)Risk CategoryClinical SignificanceRecommended Action
<40<40Very LowMay indicate underlying conditionInvestigate cause with healthcare provider
40-8040-80OptimalLow cardiovascular riskMaintain healthy lifestyle
81-10081-100BorderlineModerate riskImplement lifestyle changes
101-130101-130HighElevated cardiovascular riskConsider medication with lifestyle changes
>130>130Very HighSignificant cardiovascular riskMedication typically necessary

Risk categories based on primary prevention guidelines. Individuals with existing cardiovascular disease or diabetes should aim for lower targets.

The Benefits of Low ApoB Levels

Low ApoB levels are generally associated with reduced cardiovascular disease risk. Studies have consistently shown that individuals with lower ApoB concentrations have fewer heart attacks, strokes, and other cardiovascular events. This protective effect occurs because fewer atherogenic particles mean less opportunity for arterial wall penetration and plaque formation.

The cardiovascular benefits of low ApoB extend beyond just reduced event risk. People with lower ApoB levels often experience:

  • Slower progression of atherosclerosis
  • Better endothelial function (healthier blood vessel lining)
  • Reduced inflammation in arterial walls
  • Lower risk of peripheral artery disease
  • Decreased likelihood of needing cardiovascular interventions

Population studies have found that individuals with genetically low ApoB levels tend to live longer with lower rates of cardiovascular disease, suggesting that maintaining low ApoB throughout life provides cumulative benefits for heart health and longevity.

Optimal ApoB Ranges: What Should You Aim For?

Understanding optimal ApoB ranges helps you set appropriate health goals. While laboratory reference ranges vary, cardiovascular experts generally recommend more aggressive targets for optimal health.

For primary prevention (individuals without established cardiovascular disease), most experts recommend keeping ApoB below 80 mg/dL. However, for those with diabetes, metabolic syndrome, or a strong family history of heart disease, a target below 70 mg/dL may be more appropriate.

Secondary prevention targets are even more aggressive. If you've already had a cardiovascular event or have established atherosclerosis, guidelines suggest aiming for ApoB levels below 65 mg/dL, with some experts advocating for levels below 50 mg/dL in very high-risk individuals.

Age and Gender Considerations

ApoB levels naturally vary with age and gender. Premenopausal women typically have lower ApoB levels than men of the same age, partly due to estrogen's protective effects. After menopause, women's ApoB levels often increase, sometimes surpassing those of age-matched men. Children and young adults generally have the lowest ApoB levels, which tend to rise with age due to lifestyle factors and metabolic changes.

When Low ApoB Might Be Concerning

While low ApoB is generally beneficial, extremely low levels—typically below 40 mg/dL—may warrant investigation. Such levels could indicate underlying health conditions that affect lipid metabolism or absorption.

Conditions associated with very low ApoB include:

  • Hypobetalipoproteinemia: A genetic condition affecting ApoB production
  • Malabsorption disorders: Conditions like celiac disease or Crohn's disease
  • Severe liver disease: The liver produces ApoB, so dysfunction can lower levels
  • Hyperthyroidism: Overactive thyroid can accelerate lipid metabolism
  • Malnutrition: Severe dietary restrictions or eating disorders

If your ApoB is extremely low without an obvious cause like medication or strict dietary changes, consult with your healthcare provider. They may recommend additional testing to rule out underlying conditions, especially if you're experiencing symptoms like fatty stools, vitamin deficiencies, or unexplained weight loss.

Genetic Factors and Family History

Some individuals have genetically low ApoB levels due to variants in genes like APOB, PCSK9, or ANGPTL3. These genetic variations are generally beneficial and associated with lifelong protection against cardiovascular disease. However, rare mutations causing extremely low ApoB (familial hypobetalipoproteinemia) can sometimes lead to fat malabsorption and vitamin deficiencies, requiring monitoring and potential supplementation.

How to Achieve and Maintain Healthy Low ApoB Levels

Achieving optimal ApoB levels often requires a comprehensive approach combining lifestyle modifications with, in some cases, medical interventions. The good news is that ApoB responds well to both dietary changes and medications, giving you multiple tools to reach your target.

Dietary Strategies

Your diet significantly impacts ApoB levels. Focus on:

  • Reducing saturated fat intake: Limit red meat, full-fat dairy, and tropical oils
  • Eliminating trans fats: Avoid partially hydrogenated oils in processed foods
  • Increasing soluble fiber: Oats, beans, apples, and psyllium can lower ApoB
  • Adding plant sterols: Found in fortified foods or supplements
  • Emphasizing omega-3 fatty acids: From fatty fish, walnuts, and flaxseeds

The Mediterranean diet pattern, rich in vegetables, fruits, whole grains, legumes, nuts, and olive oil, has been shown to effectively lower ApoB levels while providing numerous other health benefits.

Lifestyle Modifications

Beyond diet, several lifestyle factors influence ApoB levels:

  • Regular exercise: Both aerobic and resistance training lower ApoB
  • Weight management: Even modest weight loss can improve levels
  • Smoking cessation: Smoking increases ApoB and overall cardiovascular risk
  • Moderate alcohol consumption: If you drink, limit intake as excess raises ApoB
  • Stress management: Chronic stress can negatively impact lipid metabolism

Medical Interventions

When lifestyle changes aren't sufficient, medications can effectively lower ApoB. Statins remain the first-line therapy, typically reducing ApoB by 30-50%. For those needing additional lowering, options include ezetimibe (10-15% reduction), PCSK9 inhibitors (50-60% reduction), and bempedoic acid (15-20% reduction). Your healthcare provider can help determine the best approach based on your individual risk factors and response to treatment. Regular monitoring ensures you're achieving and maintaining your target ApoB levels.

Monitoring Your ApoB: Testing Frequency and Interpretation

Regular ApoB monitoring helps track your cardiovascular risk and treatment effectiveness. For most adults, annual testing is appropriate if levels are optimal. However, more frequent monitoring—every 3-6 months—is recommended when starting or adjusting treatments, or if you have elevated levels or cardiovascular risk factors.

When interpreting results, consider ApoB alongside other markers. The ApoB/ApoA1 ratio provides additional risk stratification, with ratios below 0.7 considered optimal. Discordance between ApoB and LDL-C is common—if your LDL-C is normal but ApoB is elevated, your cardiovascular risk is better reflected by the ApoB value.

Track your ApoB trends over time rather than focusing on single measurements. Consistent downward trends indicate successful risk reduction, while rising levels suggest the need for treatment intensification. Document lifestyle changes and medications alongside your results to understand what strategies work best for you.

The Bottom Line: Embracing Low ApoB for Long-Term Health

Low ApoB cholesterol is indeed good for your health, offering powerful protection against cardiovascular disease—our leading cause of death globally. By maintaining ApoB levels below 80 mg/dL (or lower if you have additional risk factors), you significantly reduce your likelihood of heart attacks, strokes, and other cardiovascular events.

While extremely low levels warrant investigation to rule out underlying conditions, for most people, achieving and maintaining low ApoB through lifestyle modifications and, when necessary, medications represents one of the most effective strategies for cardiovascular disease prevention. Regular testing allows you to track your progress and adjust your approach as needed.

Remember that cardiovascular health is multifaceted. While optimizing your ApoB is crucial, combine this with blood pressure control, blood sugar management, regular physical activity, and not smoking for comprehensive cardiovascular protection. Your future self will thank you for the investment in maintaining healthy ApoB levels today.

References

  1. Sniderman AD, Thanassoulis G, Glavinovic T, et al. Apolipoprotein B Particles and Cardiovascular Disease: A Narrative Review. JAMA Cardiol. 2019;4(12):1287-1295.[Link][PubMed][DOI]
  2. Ference BA, Kastelein JJP, Ray KK, et al. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants With Risk of Coronary Heart Disease. JAMA. 2019;321(4):364-373.[PubMed][DOI]
  3. Langlois MR, Nordestgaard BG, Langsted A, et al. Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM. Clin Chem Lab Med. 2020;58(4):496-517.[PubMed][DOI]
  4. Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020;41(1):111-188.[PubMed][DOI]
  5. Richardson TG, Sanderson E, Palmer TM, et al. Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis. PLoS Med. 2020;17(3):e1003062.[PubMed][DOI]
  6. Hagström E, Steg PG, Szarek M, et al. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab. Circulation. 2022;146(9):657-672.[PubMed][DOI]

Frequently Asked Questions

How can I test my ApoB at home?

You can test your ApoB at home with SiPhox Health's Apob Advanced Cholesterol Panel, which includes ApoB testing along with ApoA, LDL-C, HDL-C, total cholesterol, and triglycerides. For ongoing monitoring, the Heart & Metabolic Program includes ApoB testing at your chosen frequency.

What is the ideal ApoB level for cardiovascular health?

For optimal cardiovascular health, aim for ApoB levels below 80 mg/dL if you have no risk factors. Those with diabetes, metabolic syndrome, or family history of heart disease should target below 70 mg/dL, while individuals with existing cardiovascular disease should aim for below 65 mg/dL.

How quickly can I lower my ApoB levels?

With dietary changes and exercise, you may see ApoB reductions of 10-20% within 4-6 weeks. Medications like statins can lower ApoB by 30-50% within 6-8 weeks. The rate of change depends on your baseline levels, the interventions used, and individual response to treatment.

Is ApoB better than LDL cholesterol for assessing heart disease risk?

Yes, research shows ApoB is a superior predictor of cardiovascular disease compared to LDL cholesterol. While LDL-C measures cholesterol content, ApoB counts all atherogenic particles that can cause plaque buildup. Many experts now consider ApoB the most accurate lipid marker for cardiovascular risk assessment.

Can ApoB levels be too low?

While low ApoB is generally beneficial, extremely low levels below 40 mg/dL may indicate underlying conditions like malabsorption disorders, liver disease, or genetic conditions. If your ApoB is very low without clear cause, consult your healthcare provider for further evaluation.

Related Articles

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details